Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 250 results in range #21 to #270.
- 4-Dimethylaminophenol (1 revision)
- "template:ArashM" (1 revision)
- "template:CA" (1 revision)
- "template:F.K" (1 revision)
- "template:FI" (1 revision)
- "template:Fereshteh karegar (1 revision)
- 60S ribosomal protein L19 (1 revision)
- 60S ribosomal protein L5 (1 revision)
- 60S ribosomal protein L35a (1 revision)
- 72F fusion protein (1 revision)
- "template:S.C" (1 revision)
- "template:Saba Iqbal" (1 revision)
- "template:Saba Iqbal.awan" (1 revision)
- "template:W.A" (1 revision)
- "template:WA" (1 revision)
- 5,6-MDO-DiPT (1 revision)
- '''Dr.Prof. Mohammed Abdulwahab AlKhateeb''' -- MD.,FICMS.,-CHIEF CONSULTATNT IN GENERAL INTERNAL MEDICINE, CARDIOLOGY & HEPATOBILIARY DISEASES (1 revision)
- 5-MeO-DMT (1 revision)
- ''sandbox:M.S" (1 revision)
- 4-HO-DiPT (1 revision)
- 'Lab Lemco' powder (1 revision)
- (-)-1-Phenyl-2-propylaminopentane (1 revision)
- 5-Methyltetrahydrofolate (1 revision)
- (-)-2β-Carbomethoxy-3β-phenyltropane (1 revision)
- (-)-Methyl-1-methyl-4β-(2-naphthyl)piperidine-3β-carboxylate (1 revision)
- 4-HO-DET (1 revision)
- 5-alpha-reductase deficiency secondary prevention (1 revision)
- 6-Pyruvoyltetrahydropterin synthase deficiency (1 revision)
- 4-Hydroxytestosterone (1 revision)
- 60S ribosomal protein L18 (1 revision)
- 60S ribosomal protein L14 (1 revision)
- 60S ribosomal protein L23 (1 revision)
- -omics (1 revision)
- 0-0-1-3 (1 revision)
- 0-3 (1 revision)
- 1,1'-Bi-2-naphthol (1 revision)
- 1,1'-bi-2-naphthol (1 revision)
- 1,1,2,2-Tetrachloroethane (1 revision)
- 1,1,2-Trichloroethane (1 revision)
- 1,2-Dichloroethane (1 revision)
- 1,2-rearrangement (1 revision)
- 1,3-Bisphosphoglycerate (1 revision)
- 1,3-Butadiene (1 revision)
- 1,3-Dipolar cycloaddition (1 revision)
- 40S ribosomal protein S7 (1 revision)
- 40S ribosomal protein S14 (1 revision)
- 40S ribosomal protein S26 (1 revision)
- 1,4-Dichlorobenzene (1 revision)
- 1,4-Dioxane (1 revision)
- 1,5-Pentanediol (1 revision)
- 1,8-Bis(dimethylamino)naphthalene (1 revision)
- 1,8-Diazabicycloundec-7-ene (1 revision)
- 1-(3-Chlorophenyl)piperazine (1 revision)
- 4-Acetoxy-DET (1 revision)
- 100% English (1 revision)
- 108 form Wu family T'ai Chi Ch'uan (1 revision)
- 11-Hydroxy-THC (1 revision)
- 5-MeO-DALT (1 revision)
- 5-Hydroxytryptophan (1 revision)
- 22q11.2 deletion syndrome echocardiography or ultrasound (1 revision)
- 3-Methylcrotonyl-CoA carboxylase deficiency (1 revision)
- 5'-phosphoribosyl-5-aminoimidazole (1 revision)
- 2C-TFM (1 revision)
- 3 hydroxyisobutyric aciduria (1 revision)
- 5-Methoxy-diisopropyltryptamine (1 revision)
- 5-MeO-NMT (1 revision)
- 5-alpha-reductase deficiency electrocardiogram (1 revision)
- 2β-propanoyl-3β-(4-tolyl)-tropane (1 revision)
- 8-Aminoquinoline (1 revision)
- 310 helix (1 revision)
- 3-Quinuclidinyl benzilate (1 revision)
- 22q11.2 deletion syndrome case study one (1 revision)
- 7-Dehydrocholesterol reductase (1 revision)
- 7-Amino-actinomycin D (1 revision)
- 5,6-MDO-MiPT (1 revision)
- 3C-P (1 revision)
- 40S ribosomal protein S24 (1 revision)
- 60S ribosomal protein L4 (1 revision)
- 2C-B-BZP (1 revision)
- 3-methylglutaconic acid (1 revision)
- 2C-B-FLY (1 revision)
- 2C-I (1 revision)
- 13q deletion syndrome (1 revision)
- 60S ribosomal protein L29 (1 revision)
- 60S ribosomal protein L28 (1 revision)
- 60S ribosomal protein L26 (1 revision)
- 60S ribosomal protein L13 (1 revision)
- 4-MeO-MiPT (1 revision)
- 16S ribosomal RNA (1 revision)
- 3-Aminoisobutyric acid (1 revision)
- 4-MTA (1 revision)
- 60S ribosomal protein L12 (1 revision)
- 60S ribosomal protein L39 (1 revision)
- 60S ribosomal protein L37a (1 revision)
- 5' flanking region (1 revision)
- 2nd Skin (1 revision)
- 2b3a (1 revision)
- 60S ribosomal protein L9 (1 revision)
- 5,6-MeO-MiPT (1 revision)
- 60S ribosomal protein L11 (1 revision)
- 9-1-1 (1 revision)
- 40S ribosomal protein S19 (1 revision)
- 5-MeS-DMT (1 revision)
- 9q34 deletion syndrome (1 revision)
- 40S ribosomal protein S3 (1 revision)
- 40S ribosomal protein S5 (1 revision)
- 2C-D (1 revision)
- 5'-3' exoribonuclease 1 (1 revision)
- Ф29 phage (1 revision)
- 23andMe (1 revision)
- 4-Methylthioamphetamine (1 revision)
- 3-Hydroxyacyl ACP dehydrase (1 revision)
- 5-MeO-AET (1 revision)
- 5-Formamidoimidazole-4-carboxamide ribotide (1 revision)
- 5-alpha-reductase deficiency future or investigational therapies (1 revision)
- 5,10-Methylenetetrahydrofolate (1 revision)
- 5-bromouracil (1 revision)
- 5-MeO-DET (1 revision)
- 5-Lipoxygenase activating protein (1 revision)
- 2β-propanoyl-3β-(2-naphthyl)-tropane (1 revision)
- 4-HO-MET (1 revision)
- 2α-(Propanoyl)-3β-(2-(6-methoxynaphthyl))-tropane (1 revision)
- 5-Hydroxyindoleacetic acid (1 revision)
- 17-beta-hydroxysteroid dehydrogenase deficiency x ray (1 revision)
- 60S ribosomal protein L17 (1 revision)
- 2C-T-7 (1 revision)
- 3,4-Diaminopyridine (1 revision)
- 3,4-Dimethylamphetamine (1 revision)
- 24-Dehydrocholesterol reductase (1 revision)
- 5-HT receptor (1 revision)
- 4-Chloroindole-3-acetic acid (1 revision)
- 5-alpha-reductase deficiency primary prevention (1 revision)
- 3-Methylglutaconyl CoA (1 revision)
- 5-alpha-reductase deficiency case study one (1 revision)
- 5-Methyltetrahydrofolate-homocysteine methyltransferase (1 revision)
- 4-HO-DPT (1 revision)
- 3-Ureidopropionic acid (1 revision)
- 5-MeO-pyr-T (1 revision)
- 5'-phosphoribosyl-4-carboxy-5-aminoimidazole (1 revision)
- 999 (emergency telephone number) (1 revision)
- 8-Hyydroxyquinoline (1 revision)
- 2C-B (1 revision)
- 5-MeO-DPT (1 revision)
- 5,6-MDO-DMT (1 revision)
- 3-dehydrosphinganine reductase (1 revision)
- 40S ribosomal protein S8 (1 revision)
- 40S ribosomal protein S28 (1 revision)
- 5-Methylcytosine (1 revision)
- 18-Methoxycoronaridine (1 revision)
- 18S ribosomal RNA (1 revision)
- 5-Methylindole (1 revision)
- 1993 Clinton health care plan (1 revision)
- 1998 Klang Valley water crisis (1 revision)
- 1 E-10 m (1 revision)
- 1 E-11 m (1 revision)
- 1 E7 s (1 revision)
- 1p36 deletion syndrome (1 revision)
- 5-alpha-reductase deficiency cost-effectiveness of therapy (1 revision)
- 2,2,2-Trichloroethanol (1 revision)
- 2,2,4-Trimethylpentane (1 revision)
- 2,3,4,5-Tetramethoxyamphetamine (1 revision)
- 2,3-Bisphosphoglycerate (1 revision)
- 2,3-Dihydropyran (1 revision)
- 2,3-Dihydroxy-3-methylpentanoic acid (1 revision)
- 2,3-squalene oxide (1 revision)
- 2,4,5-Trichlorophenoxyacetic acid (1 revision)
- 4-HO-MPT (1 revision)
- 4-HO-pyr-T (1 revision)
- 2,4-Dichlorophenol (1 revision)
- 2,4-Dinitrophenol (1 revision)
- 5-hydroxytryptophan (1 revision)
- 60S ribosomal protein L30 (1 revision)
- 4-Hydroxy-4-methylpentanoic acid (1 revision)
- 2,4 Dienoyl-CoA reductase deficiency (1 revision)
- 5q- syndrome (1 revision)
- 2,5-Dimethoxy-4-ethylamphetamine (1 revision)
- 2,5-Dimethoxy-4-iodoamphetamine (1 revision)
- 4,5-MDO-DMT (1 revision)
- 2,5-Dimethoxy-4-nitroamphetamine (1 revision)
- 2,5-Dimethoxyphenethylamine (1 revision)
- 2,5-Dimethylfuran (1 revision)
- 2R hypothesis (1 revision)
- 60S ribosomal protein L15 (1 revision)
- 60S ribosomal protein L18a (1 revision)
- 3 beta-hydroxysteroid dehydrogenase deficiency historical perspective (1 revision)
- 2-Acetylaminofluorene (1 revision)
- 2-Aminoethoxydiphenyl borate (1 revision)
- 2-Aminomuconic acid (1 revision)
- 60S ribosomal protein L23a (1 revision)
- 3 methylcrotonic aciduria (1 revision)
- 60S ribosomal protein L21 (1 revision)
- 60S ribosomal protein L27a (1 revision)
- 2-Bromopropane (1 revision)
- 2-Butyl-3-(p-tolyl)quinuclidine (1 revision)
- 2-Chlorophenol (1 revision)
- 2-Ethylhexanol (1 revision)
- 60S ribosomal protein L32 (1 revision)
- 2-Hydroxyglutaricaciduria (1 revision)
- 2-Iodoxybenzoic acid (1 revision)
- 2-Isopropyl-5-methyl-1-(2,6-dihydroxy-4-nonylphenyl)cyclohex-1-ene (1 revision)
- 2-Me-DET (1 revision)
- 2-Methyl-2-nitrosopropane (1 revision)
- 2-Methyl-3,3-diphenyl-3-propanolamine (1 revision)
- 2-Methyl-4-Chlorophenoxyacetic Acid (1 revision)
- 2-Methylbutyryl-CoA (1 revision)
- 2-Methylbutyryl-CoA dehydrogenase deficiency (1 revision)
- 2-Nitropropane (1 revision)
- 2-Nonenal (1 revision)
- 60S ribosomal protein L37 (1 revision)
- 2-Phenylphenol (1 revision)
- 2-Pyridone (1 revision)
- 2-Pyrone (1 revision)
- 2-chloroethanol (1 revision)
- 2-hydroxyphytanoyl-CoA lyase (1 revision)
- 60S ribosomal protein L41 (1 revision)
- 2-propanoyl-3-(4-isopropylphenyl)-tropane (1 revision)
- 60S ribosomal protein L7a (1 revision)
- 68W (1 revision)
- 60S ribosomal protein L8 (1 revision)
- 2007 WikiDoc Foundation Scholars (1 revision)
- 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (1 revision)
- 3T3-L1 (1 revision)
- 3m syndrome (1 revision)
- 8-cell stage (1 revision)
- 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay (1 revision)
- 60S ribosomal protein L10 (1 revision)
- 3-Aminopyridine (1 revision)
- 21-Hydroxylase Deficiency (patient information) (1 revision)
- A1CF (1 revision)
- A-box 1 of insulin gene (1 revision)
- 3β-(4'-chlorophenyl)-2β-(3'-phenylisoxazol-5'-yl)tropane (1 revision)
- 4-Nitroaniline (1 revision)
- A2ML1 (1 revision)
- A4GALT (1 revision)
- 4-Oxalocrotonate tautomerase (1 revision)
- 40S ribosomal protein S13 (1 revision)
- 40S ribosomal protein S18 (1 revision)
- 40S ribosomal protein S15a (1 revision)
- 4,5-MDO-DiPT (1 revision)
- 40S ribosomal protein S23 (1 revision)
- 40S ribosomal protein S11 (1 revision)
- 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (1 revision)
- 4-Acetoxy-DIPT (1 revision)
- 40S ribosomal protein S4, Y isoform 2 (1 revision)
- 40S ribosomal protein S4, Y isoform 1 (1 revision)
- 4-Aminobiphenyl (1 revision)
- 3-hydroxyisobutyrate dehydrogenase (1 revision)
- 454 Life Sciences (1 revision)
- 4-Aminoquinoline (1 revision)
- 4-Androstene-3,6,17-trione (1 revision)